Arno Hänninen
MD, PhD, Adj. prof.
Medical microbiology and immunology arno.hanninen@utu.fi +358 29 450 4545 +358 50 511 9870 Kiinamyllynkatu 10 Turku : 7022 |
clinical immunology; autoimmune diseases (SLE and other SARD) and their diagnostics, immune deficiencies and their diagnostics
Novel aspects of individually imprinted immune reactivity in SLE and its relevance to clinical prognosis. (InFLAMES Flagship)
Present affiliation: Principal investigator (InFLAMES consortium and Institute of Biomedicine,University of Turku), Clinical teacher (Institute of Biomedicine) . Cheaf physician, Turku University Hospital Laboratory Division.
Past affiliations: Academy of Finland Research Fellow; Prinicpal investigator in Center of Excellence in Cell Traffic (Academy of Finland affiliated), Postdoctoral researcher, WEHI (Walter and Eliza Hall Institute); Melbourne, Australia, PhD student and postdoc in Medical microbiology and Immunology (MediCity).
My current research focus is on rheumatic diseases, in particular SLE (systemic lupus erythematosus) and its immune pathogenesis. In a prospective follow-up study together with a group of rheumatologists and as part of the InFLAMES reseach consortium, we aim to identify individual variation in circulating leukocyte populations using approaches, which imitate the pressure exerted to our immun system by micobes. When combined to clinical follow-up data and extended laboratory parameters this allows us to seek for novel aspects on the potential role of different classes of microbes and microbiome in the pathogenesis of SLE, and for novel biomarkers of prognostic value in evaluation of disease course and disease activity (flares).
I have a long track record also in studying the immunological disease mechanims in autoimmune type 1 diabetes, especally from the point of view of how gut immune system and gut microbiome (dys)balance link to initiation of the autoimmune process. Related to this, my interest in functional profiling of gut microbiota has spurred our bioinformatics and proteomics experts to develop proteome-analytics towards this. As the final project in gut microbiota studies, our present goal is to find out to which extent the microbial strains in infants differ from individual to individual in their capability to utilize human milk oligosaccharides and complex carbohydrates present in baby foods, and to which extent this determines the development of a diverse and resilient microbial communiities.
In my occupation as a chief doctor in immunological diagnostics in the university hospital laboratry, I am involved in clinical resesarch in rare immune deficiencies. Together with clinical researchers of other wellbeing services counties I also direct egistry-based investigation of serological markers in autoimmune myopathies and their effectiveness in disease prediction.
Clinical and basic immunology, clinical microbiology.
As a clinical teacher, I have responsibilities in organizing, implementing and developing the education of medical doctors, dentists and master students in biomedicine in the fields of microbiology and immunology.
- Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety (2018)
- Molecular therapy. Methods & clinical development
- Faecalibacterium prausnitzii Treatment Improves Hepatic Health and Reduces Adipose Tissue Inflammation in High-fat Fed Mice (2017)
- ISME Journal
- Gut dysbiosis induces dendritic-cell traffic from colon to pancreatic lymph node: implications for activation of islet-reactive T cells in type 1 diabetes (2017)
- Scandinavian Journal of Immunology
- Immunomonitoring of patients treated with mesenchymal stromal cells for steroid-refractory severe graft-versus-host disease (2017)
- Cytotherapy
- Infections in MS: An innate immunity perspective (2017)
- Acta Neurologica Scandinavica
- Tyypin 1 diabetes ja autoimmuniteetin yhteys ympäristöömme (2017)
- Duodecim
- Activation of plasmacytoid dendritic cells by apoptotic particles: mechanism for the loss of immunological tolerance in androgen-depleted Sjogren's syndrome (2016)
- Scandinavian Journal of Rheumatology
- Activation of Plasmacytoid Dendritic Cells by Apoptotic Particles - Mechanism for The Loss of Immunologic Tolerance in Androgen-Depleted Sjögren's Syndrome (2016)
- Annals of the Rheumatic Diseases
- Activation of Plasmacytoid Dendritic Cells in Colon-Draining Lymph Nodes during Citrobacter rodentium Infection Involves Pathogen-Sensing and Inflammatory Pathways Distinct from Conventional Dendritic Cells (2016)
- Journal of Immunology
- Activation of plasmacytoid dendritic cells in colon-draining lymph nodes during C. rodentium infection involves pathogen-sensing and inflammatory pathways distinct from CD103(+) DC (2016)
- European Journal of Immunology
- Immunomonitoring of patients treated with mesenchymal stromal cells for graft versus host disease: a case study (2016)
- Scandinavian Journal of Immunology
- Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure (2016)
- PLoS ONE
- Tumavasta-aineet systeemisten sidekudostautien diagnostiikassa (2016)
- BestPractice Reumataudit
- Autoimmunity, hypogammaglobulinemia, lymphoproliferation and mycobacterial disease in patients with dominant activating mutations in STAT3 (2015)
- Blood
- Immuntolerans (2015)
- Finska Läkaresällskapets Handlingar
- Islet-associated T-cell receptor-β CDR sequence repertoire in prediabetic NOD mice reveals antigen-driven T-cell expansion and shared usage of VβJβ TCR chains (2015)
- Molecular Immunology
- On the role of gut bacteria and infant diet in the development of autoimmunity for type 1 diabetes (2015)
- Diabetologia
- Peritoneal Cavity is a Route for Gut-Derived Microbial Signals to Promote Autoimmunity in Non-Obese Diabetic Mice (2015)
- Scandinavian Journal of Immunology
- Systemic Manifestations of Mucosal Diseases: Trafficking of Gut Immune Cells to Joint, Liver, and Pancreas (2015) Mucosal Immunology Salmi M, Adams DH, Trivedi P, Hänninen A, Jalkanen S
- Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta (2015)
- Journal of Neuroimmunology